- CA$63.16m
- CA$78.46m
- CA$0.41m
- 28
- 13
- 57
- 24
Annual cashflow statement for MedMira, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.316 | -0.505 | -1.88 | -1.27 | -2.94 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.316 | -0.505 | -1.88 | -1.27 | -2.94 |
| Capital Expenditures | -0.102 | -0.037 | -0.07 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | -0.001 | -0.743 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.102 | -0.037 | -0.07 | -0.001 | -0.743 |
| Financing Cash Flow Items | — | -0.001 | 0.469 | 0.277 | 5.22 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.731 | 0.139 | 1.99 | 1.25 | 5.77 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.313 | -0.402 | 0.033 | -0.02 | 2.08 |